NCT03814109

Efficacy and Safety of Leningrado Association in the Treatment of Hypertension

Randomized, Double-blind, Triple-dummy, National, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Leningrado Association in the Treatment of Hypertension

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: EMS · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Leningrado association on the treatment of hypertension.

Conditions

• Arterial Hypertension

Interventions

Type	Name	Description
DRUG	LENINGRADO association	1 coated sustained-release tablet, oral, once a day.
DRUG	Indapamide SR 1.5 MG	1 coated sustained-release tablet, oral, once a day.
DRUG	Levamlodipine 2.5/ 5 mg	1 tablet, oral, once a day.
OTHER	Leningrado association Placebo	1 coated sustained-release tablet, oral, once a day.
OTHER	Indapamide SR Placebo	1 coated sustained-release tablet, oral, once a day.
OTHER	Levamlodipine placebo	1 tablet, oral, once a day.

Timeline

• Start date: 2022-04-01
• Primary completion: 2023-11-01
• Completion: 2024-01-01
• First posted: 2019-01-23
• Last updated: 2022-07-27